BIMA House Day 1: How AI Is Reshaping Health Behaviours: Frontier Insights by frog

Healthcare is entering a period of profound change, shaped by accelerating advances in AI, shifting patient expectations, and growing pressure on global health systems. AI is rapidly changing how people understand, manage and engage with their health – from how patients make decisions to how providers design care, services and experiences. In this frog‑led panel, we’ll launch findings from Frontier Health Behaviours in an Age of AI, a new primary research study exploring how AI is reshaping patient and provider behaviours across healthcare, life sciences, medtech, insurance and consumer health.

Drawing on cutting‑edge behavioural insights, the session will unpack what’s changing, why it matters now, and what it means for organisations shaping the future of health. Join senior healthcare leaders as they share the research, debate real‑world implications, and explore how businesses can respond with more human, trusted and effective AI‑enabled health experiences.

What to expect:

• A high‑level view of the key healthcare trends shaping the next decade, drawing on frog’s recent Futurescape insight report to set the strategic context.
• An exclusive first look at new primary research uncovering emerging patient and provider behaviours in an age of AI
• Fresh insight into how AI is reshaping health decision‑making, trust and engagement
• Real‑world perspectives from industry and design leaders, exploring what these frontier behaviours mean for healthcare, life sciences and consumer health organisations
• Practical implications for leaders responsible for AI‑enabled experiences, from product and platform design to services, communications and policy
• A candid panel discussion and audience Q&A, focused on building more human‑centred, trusted and effective AI‑powered health experiences

Who is it for?

• Future-thinking leaders from healthcare, life sciences and consumer health organisations
• Product, experience design and innovation executives
• Digital, data and AI leaders shaping patient or provider platforms • Brand, marketing and customer experience leaders in regulated industries
• Strategy, insights and transformation professionals

Speakers:

Ross Landles,Vice President, Global Head of Business Reinvention

Ross Landles is Vice President and Global Head of Business Reinvention at frog, the Reinvention and Experience partner. He leads a 250-strong global strategy team that fuses creativity and strategic thinking – treating strategy as a creative act. As founder of frog’s London studio and a member of the global leadership team, Ross has driven the creation of new ventures, delivered enterprise-scale value, and cultivated cultures of innovation within some of the world’s most ambitious organizations. His work lives at the intersection of emerging technology and human experience, including pioneering applications of AI to reshape how businesses think, act, and grow. Ross will be joined by a panel of senior healthcare leaders as they share the research, debate real‑world implications, and explore how businesses can respond with more human, trusted and effective AI‑enabled health experiences.

Sylvia Park-Ekecs, Global Head of Consumer
Experience, Sanofi

As Head of Consumer Experience, Data AI & Foundations at Sanofi, Kanu Goel works at the seam where healthcare, AI, and medtech converge, designing for the patient holding the device, the clinician prescribing it, and the caregiver between them. Her work spans human-centered, AI-enabled experiences across drug, device, and digital touchpoints: connected care ecosystems, AI-augmented clinical workflows, and the behavioral design of medtech that people actually want to use.

Kanu’s work has earned global recognition for the value it creates across the healthcare experience, for patients, for caregivers, and for the clinicians delivering their care. That recognition includes iF Design Gold, Red Dot, Good Design, and other honors for ecosystem thinking and experience design in healthcare, alongside wide coverage in Fast Company, Wired, Dezeen, and leading pharma and medtech publications, with commentary sought by outlets including the BBC.

A systems thinker and behavioral designer, she is a vocal advocate for the kind of AI pharma actually needs: one that works inside heavy regulation and imperfect data, defers when humans should decide, and earns trust by design, evidence, and discipline.